Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses
Yasuhiro Fudaba(Harvard University), Megan Sykes(Columbia University Irving Medical Center), Robert B. Colvin(Harvard University), Thierry Bonnefoix(Inserm), Annette B. Kraus(Harvard University), Thomas R. Spitzer(Harvard University), Susan L. Saidman(Harvard University), Thomas Fehr(University Hospital of Zurich), David H. Sachs(Harvard University), Nina Tolkoff-Rubin(Harvard University), Frederic I. Preffer(Massachusetts General Hospital), Kristin Kattleman(Harvard University), Karen A. Power(University College Dublin), A. Benedict Cosimi(Massachusetts General Hospital), Francis L. Delmonico(Massachusetts Medical Society), B Dey(Harvard University), Tatsuo Kawai(Harvard University), S McAfee(Harvard University), Juanita Shaffer(Harvard University)
Cited by 260
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k